Skip to main content

Arcoma receives first order for the new product, Arcoma Precision i5

2020-03-24PRESSRELEASE Arcoma receives first order for the new product, Arcoma Precision i5
Arcoma AB has received the first order for the new product Arcoma Precision i5, which was launched on March 12, 2020.The order was placed by Mediel AB, Arcoma’s distributor in Sweden and the X-ray system will be delivered to Helsingborg hospital during the third quarter of 2020.“It is extra encouraging to receive a first order immediately after launch of a new product. This confirms that the Arcoma Precision i5 is well positioned to meet customer needs. In these difficult times, with the Covid-19 pandemic and the challenges we see in society, new business is a reminder and a consolation that there is hope for a brighter future ”says Jesper Söderqvist, CEO of Arcoma AB.
About ArcomaArcoma, with long experience in the industry, is a leading provider of integrated digital X-ray systems with high quality and advanced technology. Arcoma’s products offer the latest digital imaging technology combined with technically advanced moving positioning systems and ergonomic Scandinavian design. Arcoma offers the customers complete, configurable and functional digital x-ray systems. The company’s products are sold through retailers as well as OEM customers and today there are over 3,500 of Arcoma’s X-ray systems installed worldwide. Arcoma is listed on Nasdaq First North. For more information about Arcoma, please visit www.arcoma.se

For more information, please contact:Jesper Söderqvist, Phone: +46 470 70 69 81, E-mail: jesper.soderqvist@arcoma.se. The information was submitted, through the CEO, for publication on March 24, 2020 at 08:15 AM.For more IR-related information and the possibility of pressrelease prenumeration, please visit our IR page: www.arcoma.se/about-us/investors/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.